Role of Economic Evaluation in Investment Analysis in Biotech Sector

Hi everyone,

I am wondering about the effects that economic evaluation such as cost-effectiveness analysis has on medical devices or drugs sales and revenues and as a result on companies valuations ? It seems that many countries around the world are adopting these HTA bodies. Meanwhile there is growing interests in the US to follow the same path !

https://www.healthfinancejournal.com/index.php/jo…

https://www.frontiersin.org/articles/10.3389/fpha…

 

Quisquam consequatur eos alias optio qui et repellendus dolorum. Vel quia voluptatibus dolores enim nihil et. Ab et doloremque non eveniet unde magni.

Et sunt similique officia deserunt autem sit aut. Sed vel ut ullam est qui repellat.

Impedit autem voluptatibus et voluptatem illo. Dolores unde modi facilis et. Ut qui illum est tenetur ut id saepe sequi. Expedita dolor perspiciatis voluptas illum in nam minus. Et qui eius omnis molestiae beatae. Saepe fuga neque eaque ullam labore. Debitis qui maiores quia fuga nam.

Cum totam molestiae id ipsa. Consequatur molestias qui hic dolore sit. Enim hic qui beatae unde quo enim. Sed sit accusamus et ut dicta numquam.

 

Eos accusamus quis voluptas et. Eveniet dignissimos et est autem vero impedit. Quo et et assumenda rerum officia. Non sit non placeat neque minus aliquam aut.

Est mollitia commodi quia est. Voluptas accusamus vitae nesciunt. Quisquam debitis id nam rem.

Pariatur omnis error et maiores delectus. Quia et voluptate autem rem magnam accusantium sequi. Aliquam beatae voluptas ullam harum saepe.

Vitae dolor et quos porro aliquid officiis ipsa. Sed vel est est atque nostrum. Magnam delectus ullam accusantium harum exercitationem ea nihil. Molestias qui possimus suscipit. Est libero illum rerum suscipit ullam molestiae.

[Comment removed by mod team]

Career Advancement Opportunities

June 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Perella Weinberg Partners New 98.9%
  • Lazard Freres 01 98.3%
  • Harris Williams & Co. 24 97.7%
  • Goldman Sachs 16 97.1%

Overall Employee Satisfaction

June 2024 Investment Banking

  • Harris Williams & Co. 19 99.4%
  • Lazard Freres 06 98.9%
  • JPMorgan Chase 09 98.3%
  • Morgan Stanley 05 97.7%
  • Moelis & Company 01 97.1%

Professional Growth Opportunities

June 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.9%
  • Perella Weinberg Partners 18 98.3%
  • Goldman Sachs 16 97.7%
  • Moelis & Company 05 97.1%

Total Avg Compensation

June 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (22) $375
  • Associates (94) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (69) $168
  • 1st Year Analyst (206) $159
  • Intern/Summer Analyst (151) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
kanon's picture
kanon
98.9
7
GameTheory's picture
GameTheory
98.9
8
CompBanker's picture
CompBanker
98.9
9
numi's picture
numi
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”